Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Consensus Narrative from 4 Analysts
Global Expansion And Transdermal Infusion Product Will Strengthen Future Market Presence
Key Takeaways Strategic partnerships and revenue models are driving top-line growth through diversification, increased system placements, and enhanced utilization. Geographic expansion and product innovation, including transdermal infusion development, indicate potential for future revenue growth and diversification.
View narrativeUS$11.50
FV
35.7% undervalued intrinsic discount20.22%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
Updated narrative